MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 | Zendy

ZhiDong Lv | Zendy; Dongxia Yang | Zendy; Xiangping Liu | Zendy; Liying Jin | Zendy; Xingang Wang | Zendy; Zhaochuan Yang | Zendy; Dong Liu | Zendy; Jiaojiao Zhao | Zendy; Bin Kong | Zendy; Funian Li | Zendy; Haibo Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2

Author(s) -

ZhiDong Lv,

Dongxia Yang,

Xiangping Liu,

Liying Jin,

Xingang Wang,

Zhaochuan Yang,

Dong Liu,

Jiaojiao Zhao,

Bin Kong,

Funian Li,

Haibo Wang

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000485785

Subject(s) - triple negative breast cancer , downregulation and upregulation , cancer research , vimentin , epithelial–mesenchymal transition , ectopic expression , breast cancer , microrna , cancer , biology , western blot , medicine , immunohistochemistry , cell culture , immunology , gene , biochemistry , genetics

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Our study investigated the functional role of miR-212-5p in TNBC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research